SPRYCEL
Generic Name for SPRYCEL
Dasatinib 20mg, 50mg, 70mg; 100mg; tabs.
Legal Classification:
Rx
Pharmacological Class for SPRYCEL
Tyrosine kinase inhibitor.
Manufacturer of SPRYCEL
Bristol-Myers Squibb
|
Indications for SPRYCEL
Chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy including imatinib. Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
Adult dose for SPRYCEL
Swallow whole. ≥18yrs: Chronic phase CML: 100mg once daily. Doses of up to 140mg once daily have been used. Accelerated phase CML, myeloid or lymphoid blast CML, Ph+ ALL: 140mg once daily. Doses of up to 180mg once daily have been used. Concomitant CYP3A4 inhibitors (see Interactions): consider reducing dose. Concomitant CYP3A4 inducers (see Interactions): consider increasing dose. See literature for dose adjustments with toxicity.
Children's dosing for SPRYCEL
<18yrs: not recommended.
Precautions for SPRYCEL
History of QT prolongation. Proarrhythmic conditions. Cumulative high-dose anthracycline therapy. Hypokalemia, hypomagnesemia; correct electrolyte imbalances before starting therapy. Monitor for pleural effusions. Obtain CBCs weekly for the first 2 months, then monthly thereafter. Hepatic impairment. Pregnancy (Cat.D; use adequate contraception); nursing mothers: not recommended.
Interactions for SPRYCEL
Avoid potent CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin, voriconazole), grapefruit juice. May be antagonized by CYP3A4 inducers (eg, dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, phenobarbital); St. John's wort: not recommended. Separate dosing of antacids by at least 2 hours; H2 blockers, proton pump inhibitors: not recommended. May potentiate drugs metabolized by CYP3A4 (eg, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, ergot alkaloids). Caution with concomitant anticoagulants or drugs that inhibit platelet function.
Adverse Reactions for SPRYCEL
Myelosuppression (eg, thrombocytopenia, neutropenia, anemia), fluid retention (eg, ascites, edema, pleural and pericardial effusions), GI upset, headache, dyspnea, rash, fatigue, hemorrhage (eg, CNS, GI); QT prolongation.
How is SPRYCEL supplied?
Tabs 20mg, 50mg, 70mg—60
100mg—30
Related Disease:
Leukemia, acute lymphoblastic
Leukemia, chronic myelogenous
Neoplasms